ASC-69
PD-1/PD-L1-IN-29 intermediate-2
Rosnilimab
Emfizatamab
Peresolimab
Zeluvalimab
Pucotenlimab
Reozalimab
Sudubrilimab
Retifanlimab
Erfonrilimab
Nofazinlimab
Rulonilimab
Prolgolimab
Cosibelimab
Sasanlimab
Pimivalimab
Opucolimab
Pacmilimab
Socazolimab